← Back to Search

Online Cognitive Assessment for Cancer-Related Cognitive Impairment (CAMPFIRE Trial)

N/A
Waitlist Available
Led By Michelle C Janelsins, Ph.D.
Research Sponsored by University of Rochester
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up post-study (18-20 weeks)
Awards & highlights

CAMPFIRE Trial Summary

This trial will test a new system, CAMPFIRE, which aims to help patients and clinicians track cognitive symptoms during chemotherapy.

Who is the study for?
This trial is for English-speaking cancer patients over 21 who are about to start chemotherapy, can use a computer with internet access, and have given informed consent. It's not for those hospitalized for psychiatric issues within the last year or diagnosed with neurodegenerative diseases like Alzheimer's or CNS diseases.Check my eligibility
What is being tested?
The study tests CAMPFIRE, an online system that lets cancer patients report cognitive symptoms and produces reports for doctors. It checks if CAMPFIRE is easy to use and helpful in monitoring changes during chemotherapy treatment.See study design
What are the potential side effects?
Since this trial involves an online cognitive assessment tool rather than medication, traditional side effects are not applicable. However, participants may experience discomfort or stress while answering questions about their cognitive function.

CAMPFIRE Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~post-study (18-20 weeks)
This trial's timeline: 3 weeks for screening, Varies for treatment, and post-study (18-20 weeks) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Completion
Secondary outcome measures
Changes in Cognition via NIH Toolbox Assessment
Changes in Cognition via PROMIS Surveys
Participant Feedback
+1 more

CAMPFIRE Trial Design

1Treatment groups
Experimental Treatment
Group I: CAMPFIRE AssessmentExperimental Treatment1 Intervention
NIH Toolbox Cognitive Assessment and PROMIS Surveys
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
CAMPFIRE Online Cognitive Assessment for Cancer Patients
2019
N/A
~40

Find a Location

Who is running the clinical trial?

University of RochesterLead Sponsor
840 Previous Clinical Trials
534,563 Total Patients Enrolled
Charles River AnalyticsIndustry Sponsor
2 Previous Clinical Trials
112 Total Patients Enrolled
Charles River Analytics Inc.UNKNOWN

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~6 spots leftby Apr 2025